MAP2K4 and cancer: It was found that miR-27a functioned as a tumor promoter in various cancers through targeting MAP2K4 [22], AGGF1 [23], prohibitin [24], and other genes that regulate specificity protein transcription factors and the G2-M checkpoint [25].